Unraveling the impact of chemoradiotherapy on hematopoietic function in cancer patients: a metabolomics-driven mechanistic investigation
{{output}}
Myelosuppression, a dose-limiting toxicity affecting a substantial proportion of chemotherapy patients globally (Wilson et al in Lancet Oncol 20(6):769-780, 2019. https://doi.org/10.1016/S1470-20451930163-9) remains a major clinical barrier to curative intent ... ...
